2m 2m 2m 2m 2m 2m 2m
SURROZEN (SRZN)
NASDAQ
$18.97-$0.03 (-0.16%)
Price as of Sep 11, 2026 7:30 PM EDT- $223.3MMarket Cap
- 64.28%1-Year Change
- BiotechnologyIndustry
SURROZEN (SRZN)
$18.97-$0.03 (-0.16%)
SRZN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.00 | ||
Change | -$0.45 (-2.31%) | ||
Open | $19.68 | ||
High | $19.72 | ||
Low | $18.71 | ||
Previous Close | $19.45 | ||
Volume | 145,344 | ||
30-Day Average Volume | 200,916 | ||
1-Week Change | -16.52% | ||
1-Month Change | -24.15% | ||
1-Year Change | 64.28% | ||
3-Year Change | 143.12% | ||
5-Year Change | -86.94% | ||
Fundamentals | |||
Shares Outstanding | 11.8M | ||
Total Assets | $115.6M | ||
Market Cap | $223.3M | ||
Enterprise Value | $121.3M | ||
Period: QTR TTM FY | |||
Revenue | $5.0M | ||
Net Income | $50.2M | ||
Free Cash Flow | -$7.4M | ||
EBIT | $50.2M | ||
EBITDA | $50.2M | ||
Net Working Capital | $100.4M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | 24 | ||
P/B | -1 | ||
P/E | -46 | ||
PEG | -0 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/14/2023 | ||
Earnings & Revenue